PRECIGEN INC
For the period ended Dec 31, 2023. Filed Mar 19, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 19, 2024
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of and
December 31, 2023 and 2022
| (Amounts in thousands, except share data) | 2023 | 2022 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $7,578 | $4,858 |
| Restricted cash | — | 43,339 |
| Short-term investments | 55,277 | 51,092 |
| Receivables | ||
| Trade, less allowance for credit losses of $184 as of both December 31, 2023 and 2022 | 902 | 978 |
| Other | 673 | 12,826 |
| Prepaid expenses and other | 4,325 | 5,066 |
| Total current assets | 68,755 | 118,159 |
| Property, plant and equipment, net | 7,111 | 7,329 |
| Intangible assets, net | 40,701 | 44,455 |
| Goodwill | 26,612 | 36,923 |
| Right-of-use assets | 7,097 | 8,086 |
| Other assets | 767 | 1,025 |
| Total assets | $151,043 | $215,977 |
December 31, 2023 and 2022
| (Amounts in thousands, except share data) | 2023 | 2022 |
|---|---|---|
| Liabilities and Shareholders' Equity | ||
| Current liabilities | ||
| Accounts payable | $1,726 | $4,068 |
| Accrued compensation and benefits | 8,250 | 6,377 |
| Other accrued liabilities | 6,223 | 4,997 |
| Settlement and indemnification accrual | 5,075 | 18,750 |
| Deferred revenue | 509 | 25 |
| Current portion of long-term debt | — | 43,219 |
| Current portion of lease liabilities | 1,202 | 1,209 |
| Total current liabilities | 22,985 | 78,645 |
| Deferred revenue, net of current portion | 1,818 | 1,818 |
| Lease liabilities, net of current portion | 5,895 | 6,992 |
| Deferred tax liabilities | 1,847 | 2,263 |
| Total liabilities | 32,545 | 89,718 |
| Commitments and contingencies (Note 15) | ||
| Shareholders' equity | ||
| Common stock, no par value, 400,000,000 shares authorized as of December 31, 2023 and 2022; 256,398,527 shares and 208,150,021 shares issued as of December 31, 2023 and 2022, 248,919,096 shares and 208,150,021 shares outstanding December 31, 2023 and 2022, respectively. | — | — |
| Additional paid-in capital | 2,084,916 | 1,998,314 |
| Accumulated deficit | (1,964,471) | (1,868,567) |
| Accumulated other comprehensive loss | (1,947) | (3,488) |
| Total shareholders' equity | 118,498 | 126,259 |
| Total liabilities and shareholders' equity | $151,043 | $215,977 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.